Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial. (Q48355390)

From Wikidata

Jump to navigation Jump to search

scientific article published on 12 November 2012

Language	Label	Description	Also known as
English	Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial.	scientific article published on 12 November 2012

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23151431%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23151431%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

phase III clinical trial

0 references

radiation therapy

0 references

quality of life

1 reference

based on heuristic

inferred from title

zoledronic acid

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23151431%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Gillian Duchesne

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23151431%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23151431%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

David R. H. Christie

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23151431%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

14

object named as

Brett Delahunt

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23151431%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

author name string

Chantelle Wilcox

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23151431%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

David Joseph

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23151431%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Nigel A Spry

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23151431%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

David S Lamb

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23151431%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Keen-Hun Tai

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23151431%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

John Matthews

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23151431%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Chris Atkinson

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23151431%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Sandra Turner

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23151431%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Nirdosh Kumar Gogna

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23151431%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Patrick McElduff

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23151431%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

publication date

12 November 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23151431%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Lancet Oncology Commission

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23151431%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23151431%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23151431%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1260-1270

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23151431%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Long-term followup of a randomized study of locally advanced prostate cancer treated with combined orchiectomy and external radiotherapy versus radiotherapy alone

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970423-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma--long-term results of phase III RTOG 85-31.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970423-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970423-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970423-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970423-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Duration of androgen suppression in the treatment of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970423-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970423-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Androgen deprivation therapy and estrogen deficiency induced adverse effects in the treatment of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970423-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Anaemia associated with androgen deprivation in patients with prostate cancer receiving combined hormone blockade.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970423-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced muscle strength and functional performance in men with prostate cancer undergoing androgen suppression: a comprehensive cross-sectional investigation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970423-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of fracture after androgen deprivation for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970423-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970423-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970423-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The anti-tumour activity of bisphosphonates.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970423-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970423-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Assuring high quality treatment delivery in clinical trials - Results from the Trans-Tasman Radiation Oncology Group (TROG) study 03.04 "RADAR" set-up accuracy study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970423-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Dosimetric intercomparison for multicenter clinical trials using a patient-based anatomic pelvic phantom.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970423-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Detailed review and analysis of complex radiotherapy clinical trial planning data: evaluation and initial experience with the SWAN software system

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970423-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970423-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Interpreting the significance of changes in health-related quality-of-life scores.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970423-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Rectal and urinary dysfunction in the TROG 03.04 RADAR trial for locally advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970423-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Health-related quality of life in patients with locally advanced prostate cancer after 76 Gy intensity-modulated radiotherapy vs. 70 Gy conformal radiotherapy in a prospective and longitudinal study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970423-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The quality of life of men with locally advanced prostate cancer during neoadjuvant hormone therapy: data from the Medical Research Council RT01 trial (ISRCTN 47772397).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970423-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Adverse effects to quality of life arising from treatment can recover with intermittent androgen suppression in men with prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970423-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of life and satisfaction with outcome among prostate-cancer survivors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970423-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of androgen-deprivation therapy on physical function and quality of life in men with nonmetastatic prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970423-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Intermittent androgen suppression in prostate cancer: testosterone levels and its implication.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970423-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Cognitive and mood changes in men undergoing intermittent combined androgen blockade for non-metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970423-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(12)70423-0

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23151431%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23151431%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48355390&oldid=1561961659"